⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MXCT News
MaxCyte, Inc. Common Stock
MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MXCT
MaxCyte launches CHANGE-seq-BE™ and ONE-seq-BE™ to strengthen off-target assessment for genome editing therapies
globenewswire.com
MXCT
Form 8-K
sec.gov
MXCT
MaxCyte Reports Second Quarter 2026 Financial Results
globenewswire.com
MXCT
MaxCyte® Announces Multi-Platform Technology License Partnership with Genentech® to Advance Cell Therapy Development
globenewswire.com
MXCT
MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026
globenewswire.com
MXCT
Syntax Bio Announces Expanded Series A and Leadership Appointments
businesswire.com
MXCT
Form 8-K
sec.gov
MXCT
Form 8-K
sec.gov
MXCT
Form 8-K
sec.gov
MXCT